Joshua Joo

Array ( [id] => 5743687 [patent_doc_number] => 20060089412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Pharmaceutical composition for the treatment of non-alcoholic fatty liver disease' [patent_app_type] => utility [patent_app_number] => 11/251932 [patent_app_country] => US [patent_app_date] => 2005-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2300 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20060089412.pdf [firstpage_image] =>[orig_patent_app_number] => 11251932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 131982 [patent_doc_number] => 07700653 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-20 [patent_title] => 'Halogen-substituted aminodicarboxylic acid derivatives' [patent_app_type] => utility [patent_app_number] => 11/210131 [patent_app_country] => US [patent_app_date] => 2005-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7339 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700653.pdf [firstpage_image] =>[orig_patent_app_number] => 11210131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5902525 [patent_doc_number] => 20060045905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-02 [patent_title] => 'Composition for repressing transformation growth factor beta' [patent_app_type] => utility [patent_app_number] => 11/209126 [patent_app_country] => US [patent_app_date] => 2005-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4105 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20060045905.pdf [firstpage_image] =>[orig_patent_app_number] => 11209126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7244233 [patent_doc_number] => 20050271721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Carvedilol-hydrophilic solutions' [patent_app_type] => utility [patent_app_number] => 11/204614 [patent_app_country] => US [patent_app_date] => 2005-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4435 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271721.pdf [firstpage_image] =>[orig_patent_app_number] => 11204614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6930857 [patent_doc_number] => 20050281892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Anti-tumor composition' [patent_app_type] => utility [patent_app_number] => 11/196454 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6122 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281892.pdf [firstpage_image] =>[orig_patent_app_number] => 11196454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965883 [patent_doc_number] => 20080108703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Methods for Improving Bioavailability of a Renin Inhibitor' [patent_app_type] => utility [patent_app_number] => 11/572471 [patent_app_country] => US [patent_app_date] => 2005-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6602 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108703.pdf [firstpage_image] =>[orig_patent_app_number] => 11572471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205727 [patent_doc_number] => 20070027209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Prevention and treatment of atherosclerosis with lithospermate B' [patent_app_type] => utility [patent_app_number] => 11/193355 [patent_app_country] => US [patent_app_date] => 2005-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5640 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027209.pdf [firstpage_image] =>[orig_patent_app_number] => 11193355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720203 [patent_doc_number] => 20080242726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Trans-Clomiphene for the Treatment of Benign Prostate Hypertrophy, Porstate Cancer, Hypogonadism Elevated Triglycerides and High Cholesterol' [patent_app_type] => utility [patent_app_number] => 11/571150 [patent_app_country] => US [patent_app_date] => 2005-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6709 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242726.pdf [firstpage_image] =>[orig_patent_app_number] => 11571150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6967155 [patent_doc_number] => 20050234052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Treatment for ocular infections' [patent_app_type] => utility [patent_app_number] => 11/159897 [patent_app_country] => US [patent_app_date] => 2005-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3235 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20050234052.pdf [firstpage_image] =>[orig_patent_app_number] => 11159897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748516 [patent_doc_number] => 20060111448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Methods for treating cognitive impairment in humans with multiple sclerosis' [patent_app_type] => utility [patent_app_number] => 11/133144 [patent_app_country] => US [patent_app_date] => 2005-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 64899 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111448.pdf [firstpage_image] =>[orig_patent_app_number] => 11133144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931716 [patent_doc_number] => 20050282751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Therapeutic agent for renal anemia' [patent_app_type] => utility [patent_app_number] => 11/082917 [patent_app_country] => US [patent_app_date] => 2005-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3415 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282751.pdf [firstpage_image] =>[orig_patent_app_number] => 11082917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5141295 [patent_doc_number] => 20070003511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Lipid combination to combat ashy skin' [patent_app_type] => utility [patent_app_number] => 11/083549 [patent_app_country] => US [patent_app_date] => 2005-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5113 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003511.pdf [firstpage_image] =>[orig_patent_app_number] => 11083549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005521 [patent_doc_number] => 20070203093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Antistress Agent' [patent_app_type] => utility [patent_app_number] => 11/631618 [patent_app_country] => US [patent_app_date] => 2005-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7351 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203093.pdf [firstpage_image] =>[orig_patent_app_number] => 11631618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 270226 [patent_doc_number] => 07563460 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'Enteric coated oral pharmaceutical to erode kidney stones' [patent_app_type] => utility [patent_app_number] => 11/066621 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2081 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563460.pdf [firstpage_image] =>[orig_patent_app_number] => 11066621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070345 [patent_doc_number] => 20070191447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Novel heterocyclic compound' [patent_app_type] => utility [patent_app_number] => 10/590157 [patent_app_country] => US [patent_app_date] => 2005-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28706 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191447.pdf [firstpage_image] =>[orig_patent_app_number] => 10590157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 823727 [patent_doc_number] => 07405208 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-29 [patent_title] => 'Benzoquinone ansamycins' [patent_app_type] => utility [patent_app_number] => 11/056470 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15988 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/405/07405208.pdf [firstpage_image] =>[orig_patent_app_number] => 11056470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 168630 [patent_doc_number] => 07666913 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Method of treating or preventing osteoporosis using isotaxiresinol derived from Taxus yunnanensis' [patent_app_type] => utility [patent_app_number] => 10/570252 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3599 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/666/07666913.pdf [firstpage_image] =>[orig_patent_app_number] => 10570252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4959768 [patent_doc_number] => 20080274193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Retinoic Acid-Containing Antidiabetic Agent' [patent_app_type] => utility [patent_app_number] => 10/586775 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4377 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274193.pdf [firstpage_image] =>[orig_patent_app_number] => 10586775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7181156 [patent_doc_number] => 20050124663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes' [patent_app_type] => utility [patent_app_number] => 11/036842 [patent_app_country] => US [patent_app_date] => 2005-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18836 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124663.pdf [firstpage_image] =>[orig_patent_app_number] => 11036842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4950000 [patent_doc_number] => 20080306126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Peroxisome proliferator activated receptor treatment of hyperhomocysteinemia and its complications' [patent_app_type] => utility [patent_app_number] => 11/029048 [patent_app_country] => US [patent_app_date] => 2005-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3411 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306126.pdf [firstpage_image] =>[orig_patent_app_number] => 11029048 [rel_patent_id] =>[rel_patent_doc_number] =>)